NDC Pharmacologic Class N0000175659 CD52-directed Cytolytic Antibody [EPC]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
58468-0200 | Lemtrada | Alemtuzumab | Injection, Solution, Concentrate | Intravenous | Genzyme Corporation | Human Prescription Drug |
58468-0357 | Campath | Alemtuzumab | Injection | Intravenous | Genzyme Corporation | Human Prescription Drug |
There are 2 NDC products with the pharmacologic class CD52-directed Cytolytic Antibody [EPC].